Archive - February 2020

Algomedix will be presenting scientific results at the Experimental Biology, 2020, conference which is being held from April 4^th – 7^th, 2020 in San Diego, California.

Algomedix will be present on ALGX-XC20, a Novel Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist Attenuates Joint Pain and Articular Cartilage Damage in an Osteoarthritis Rat Model on April 6^th, 2020 from 4:45 PM – 6:00 PM, at Notable Platform Presentations in Drug Discovery and Development, San Diego Convention Center.

In addition, Algomedix will be presenting on Novel TRPA1 Antagonists are Multimodal Blockers of Human TRPA1 Channels: Drug Candidates for Treatment of Familial Episodic Pain Syndrome (FEPS) on April 7^th, 2020 at the San Diego Convention Center.

Algomedix will be attending and holding partnering meetings at Biocom’s 10^th Annual Global Life Science Partnering Conference, February 25^th-27^th, 2020 in La Jolla, California.

Algomedix will be participating in the Kyoto University Life Science meeting on February 28^th, 2020 in La Jolla, California at the Sanford Consortium for Regenernative Medicine.